ProCE Banner Activity

Mechanisms of Resistance to EGFR TKI Therapy in Advanced Lung Cancer

Slideset Download
Download this brief slideset on resistance to EGFR TKI therapy in advanced EGFR-mutated NSCLC and ways it is being therapeutically addressed.

Released: November 19, 2021

Expiration: November 18, 2022

Share

Faculty

Helena Yu

Helena Yu, MD

Associate Attending
Research Director
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.

Faculty Disclosure

Primary Author

Helena Yu, MD

Associate Attending
Research Director
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York